-+ 0.00%
-+ 0.00%
-+ 0.00%

Citizens Maintains Market Outperform on Axogen, Raises Price Target to $50

Benzinga·04/29/2026 15:12:56
Listen to the news
Citizens analyst David Turkaly maintains Axogen (NASDAQ:AXGN) with a Market Outperform and raises the price target from $42 to $50.